Literature DB >> 973551

Total 5-hydroxyindoles in blood related to migraine attacks.

J R Berstad.   

Abstract

The total 5-hydroxyindoles (5HI) in whole blood were measured in 20 migraine patients during spontaneous migraine attacks and in headache-free periods. A statistically significant fall in blood 5-HI was found during headache in 17 patients suffering from classical and common migraine. In one patient with complicated migraine no change was found, and in two patients, one with common migraine and one with migraine and associated symptoms, there was a rise in total blood 5-HI during migraine attacks. The results are compared with previous findings in this field, and it is suggested that during migraine attacks there might be a rise in the plasma 5-HI. The possibility of using the 5-HI fall during spontaneous migraine attacks as a simple test for the diagnosis of migraine is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973551     DOI: 10.1111/j.1600-0404.1976.tb04360.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Alterations of cerebrospinal fluid 5-hydroxyindoleacetic acid, and total blood serotonin content during clozapine treatment.

Authors:  C M Banki
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

2.  Differential changes of blood and urinary indoleamines following intravenous ethanol administration in alcoholic and non-drinker women.

Authors:  C M Banki; M Vojnik
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

3.  Comparative simultaneous measurement of cerebrospinal fluid 5-hydroxyindoleacetic acid and blood serotonin levels in delirium tremens and clozapine-induced delirious reaction.

Authors:  C M Banki; M Vojnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

4.  Effect of intravenous infusion of amitriptyline on total blood serotonin content.

Authors:  C M Banki; M Vojnik
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.